Patent details

EP3237066 Title: POLYMORPH OF GRANATICIN B

Basic Information

Publication number:
EP3237066
PCT Application Number:
US2015067399
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP158743088
PCT Publication Number:
WO2016106326
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
POLYMORPH OF GRANATICIN B
French Title of Invention:
POLYMORPHE DE LA GRANATICINE B
German Title of Invention:
POLYMORPH VON GRANATICIN B
SPC Number:

Dates

Filing date:
22/12/2015
Grant date:
21/10/2020
EP Publication Date:
01/11/2017
PCT Publication Date:
30/06/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/10/2020
EP B1 Publication Date:
21/10/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/12/2020
Expiration date:
22/12/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/10/2020
 
 

Name:
Sloan-Kettering Institute for Cancer Research
Address:
1275 York Avenue, New York, NY 10065, United States (US)

Inventor

Name:
KUNNARI, Tero
Address:
Germany (DE)

Priority

Priority Number:
201462095850 P
Priority Date:
23/12/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/122; A61P 35/02; C07D 493/22;

Publication

European Patent Bulletin

Issue number:
202043
Publication date:
21/10/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages